- Home
- GCT vs CRGX Comparison
GCT vs CRGX Comparison
Compare GCT & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCT
- CRGX
- Stock Information
- Founded
- GCT 2019
- CRGX 2021
- Country
- GCT United States
- CRGX United States
- Employees
- GCT N/A
- CRGX N/A
- Industry
- GCT Catalog/Specialty Distribution
- CRGX
- Sector
- GCT Consumer Discretionary
- CRGX
- Exchange
- GCT Nasdaq
- CRGX Nasdaq
- Market Cap
- GCT 685.2M
- CRGX 190.0M
- IPO Year
- GCT 2022
- CRGX 2023
- Fundamental
- Price
- GCT $20.57
- CRGX $4.59
- Analyst Decision
- GCT Buy
- CRGX Hold
- Analyst Count
- GCT 2
- CRGX 7
- Target Price
- GCT $20.50
- CRGX $5.33
- AVG Volume (30 Days)
- GCT 690.1K
- CRGX 2.0M
- Earning Date
- GCT 08-05-2025
- CRGX 08-11-2025
- Dividend Yield
- GCT N/A
- CRGX N/A
- EPS Growth
- GCT 19.58
- CRGX N/A
- EPS
- GCT 3.07
- CRGX N/A
- Revenue
- GCT $1,181,871,000.00
- CRGX N/A
- Revenue This Year
- GCT $1.98
- CRGX $57.81
- Revenue Next Year
- GCT $6.50
- CRGX N/A
- P/E Ratio
- GCT $6.76
- CRGX N/A
- Revenue Growth
- GCT 42.89
- CRGX N/A
- 52 Week Low
- GCT $11.17
- CRGX $3.00
- 52 Week High
- GCT $32.43
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- GCT 59.52
- CRGX 61.56
- Support Level
- GCT $19.61
- CRGX $4.32
- Resistance Level
- GCT $21.37
- CRGX $4.63
- Average True Range (ATR)
- GCT 0.94
- CRGX 0.16
- MACD
- GCT 0.03
- CRGX 0.04
- Stochastic Oscillator
- GCT 81.46
- CRGX 76.44
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.